1st Carl Zeiss Workshop on Correlative Microscopy in Life Sciences
More than 40 scientists from all over the world. Highly productive discussions
"A concerted effort of all related disciplines along the lab workflow will be necessary to move Correlative Microscopy in Life Sciences to its next phase," stated Dr. Ulrich Simon, President and CEO of Carl Zeiss MicroImaging in his welcome address. Simon pointed out: "The goal of the workshop is to establish a common understanding of the current state of the art, define current gaps and ideally develop a plan for a concerted initiative to address the gaps."
Six exciting keynote lectures covering topics from "Cryo TEM Workflow", Jürgen Plitzko, Max-Planck-Institute of Biochemistry (Munich) to "Correlative Markers", Mark Ellisman, University of California San Diego (USCD), National Center for Microscopy and Imaging Research (NCMIR), "Integrated Systems", David Piston,Vanderbuilt University Medical Center, "Correlative Array Tomography", Roger Wepf, Electron Microscopy ETH Zürich (EMEZ), "Coordinate Transfer Concepts", Perrine Bomme, Institut Pasteur Imagopole and "FIB/SEM Workflow", Sriram Subramaniam, National Institutes of Health (NIH), illustrated the huge variety of subjects and tasks that need to be addressed. In subsequent work groups the scientists, together with R&D and product management from Carl Zeiss, discussed which topics should take center stage in future developments. Finally, the whole group focused on prioritizing the results of the work groups.
Feedback from the participants was markedly positive. The organizers of the workshop, Thomas Albrecht and Christian Boeker from Carl Zeiss, jointly responsible for Correlative Microscopy are pleased at the result: "One participant wrote to us that he felt it was one of the best meetings he'd ever been to - that's just about the best way to sum up the reactions of many participants. In addition, we have learned a lot from our guests and have a much better overview of the next steps to be taken."
Carl Zeiss AG
The Carl Zeiss Group is a leading group of companies operating worldwide in the optical and opto-electronic industries. Carl Zeiss offers innovative solutions for the future-oriented markets of Medical and Research Solutions, Industrial Solutions, Eye Care and Lifestyle Products. During fiscal year 2009/10 the group of companies generated revenues of around EUR 2.98 billion. From fiscal year 2010/11 onward, eyeglass lens manufacturer Carl Zeiss Vision will be integrated as an autonomous business group (revenues of EUR 880 million in fiscal year 2009/10). The Carl Zeiss Group now has approximately 24,000 employees, including more than 10,000 in Germany. The Carl Zeiss business groups hold leading positions in their markets. Carl Zeiss AG, Oberkochen, is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).
Carl Zeiss Microscopy
Carl Zeiss Microscopy is part of the Carl Zeiss Group.
Carl Zeiss Microscopy is one of the leading manufacturers of light and electron microscope systems and offers complete solutions for biomedical research, the healthcare sector and high-tech industries. Its product line spans from light microscopes, systems for laser scanning microscopes and spectrometry to hardware and software for image acquisition and analysis. The charged particle systems include SEMs, FESEMs, TEMs and FIB workstations along with helium ion microscopes. Service and support offerings complete the portfolio. Carl Zeiss Microscopy is headquartered in Jena, Germany. Other manufacturing and development sites are located in Oberkochen, Goettingen and Munich as well as in the United Kingdom and the United States. In the fiscal year 2009/10, the Microscopy business group of Carl Zeiss generated business revenues of approximately EUR 397 million from light microscopy products. From fiscal year 2011/12, the electron microscopy unit will be consolidated into the Microscopy business group which will create a global workforce of around 2450 people.